JP2016516790A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516790A5
JP2016516790A5 JP2016508097A JP2016508097A JP2016516790A5 JP 2016516790 A5 JP2016516790 A5 JP 2016516790A5 JP 2016508097 A JP2016508097 A JP 2016508097A JP 2016508097 A JP2016508097 A JP 2016508097A JP 2016516790 A5 JP2016516790 A5 JP 2016516790A5
Authority
JP
Japan
Prior art keywords
alkyl
group
cycloalkyl
substituted
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016508097A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516790A (ja
JP6446433B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/057234 external-priority patent/WO2014170197A1/en
Publication of JP2016516790A publication Critical patent/JP2016516790A/ja
Publication of JP2016516790A5 publication Critical patent/JP2016516790A5/ja
Application granted granted Critical
Publication of JP6446433B2 publication Critical patent/JP6446433B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016508097A 2013-04-17 2014-04-10 ピリミジン置換ピロリジン誘導体、医薬組成物及びこれらの使用 Expired - Fee Related JP6446433B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13164172.2 2013-04-17
EP13164172 2013-04-17
PCT/EP2014/057234 WO2014170197A1 (en) 2013-04-17 2014-04-10 Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2016516790A JP2016516790A (ja) 2016-06-09
JP2016516790A5 true JP2016516790A5 (enExample) 2017-06-01
JP6446433B2 JP6446433B2 (ja) 2018-12-26

Family

ID=48095739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016508097A Expired - Fee Related JP6446433B2 (ja) 2013-04-17 2014-04-10 ピリミジン置換ピロリジン誘導体、医薬組成物及びこれらの使用

Country Status (4)

Country Link
US (1) US8962641B2 (enExample)
EP (1) EP2986604B1 (enExample)
JP (1) JP6446433B2 (enExample)
WO (1) WO2014170197A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10150728B2 (en) 2013-10-17 2018-12-11 Shionogi & Co., Ltd. Alkylene derivatives
EP3265463B1 (en) 2015-03-02 2018-12-19 Apeiron Biologics AG Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases
WO2016201662A1 (en) * 2015-06-18 2016-12-22 Eli Lilly And Company Fluoropyridyl pyrazol compounds
WO2018027892A1 (en) * 2016-08-12 2018-02-15 Eli Lilly And Company Amino pyrimidine ssao inhibitors
WO2018148856A1 (en) 2017-02-14 2018-08-23 Eli Lilly And Company Diazaspirodecanyl-pyrimidine compounds useful as ssao inhibitors
IL300853A (en) 2020-08-25 2023-04-01 Lilly Co Eli Polymorphs of an ssao inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0880501A1 (en) 1996-02-02 1998-12-02 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
CA2634250A1 (en) * 2005-12-21 2007-07-05 Schering Corporation Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
CA2714703A1 (en) 2008-02-22 2009-08-27 Irm Llc Compounds and compositions as modulators of gpr119 activity
WO2012090219A2 (en) 2010-12-31 2012-07-05 Jubilant Biosys Ltd. Thiazole compounds useful as acetyl-coa carboxylase (acc) inhibitors

Similar Documents

Publication Publication Date Title
JP2016516790A5 (enExample)
JP2016506958A5 (enExample)
JP2013545791A5 (enExample)
JP2015520769A5 (enExample)
JP2017222697A5 (enExample)
JP2008531574A5 (enExample)
RU2019130519A (ru) 4-пиридоновое соединение или его соль, фармацевтическая композиция и содержащий их состав
JP2016506368A5 (enExample)
JP2016510043A5 (enExample)
JP2019514874A5 (enExample)
JP2016130266A5 (enExample)
JP2018515581A5 (enExample)
JP2017523143A5 (enExample)
JP2016514159A5 (enExample)
JP2015520140A5 (enExample)
JP2013516473A5 (enExample)
AR088043A1 (es) Mesilato de n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)fenil]acetamida monohidrato
JP2013514367A5 (enExample)
JP2016510323A5 (enExample)
JP2013544276A5 (enExample)
JP2013544854A5 (enExample)
JP2017504595A5 (enExample)
JP2016505614A5 (enExample)
CN109311812A (zh) 作为c-MET抑制剂的吡啶酮类化合物
JP2020527175A5 (enExample)